Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

South Korea is emerging as a key player in global pharmaceuticals, driven by an advanced healthcare ecosystem, strategic government initiatives, and ...

The pharmaceutical giant claims that Gutierrez Co. failed to properly design and build its manufacturing facility in Marlborough, Massachusetts.

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...